Laserfiche WebLink
Support collaborative strategic planning to address opioid misuse, <br />addiction, overdose, or related issues, including staff support, <br />facilitation services, or any activity or combination of activities <br />listed in Exhibit C to the MOA (collaborative strategic planning). <br />Evidence -based addiction treatment. <br />Support evidence -based addiction treatment consistent with the <br />American Society of Addiction Medicine's national practice <br />guidelines for the treatment of opioid use disorder — including <br />Medication -Assisted Treatment (MAT) with any medication <br />approved for this purpose by the U.S. Food and Drug <br />Administration — through Opioid Treatment Programs, qualified <br />providers of Office -Based Opioid Treatment, Federally Qualified <br />Health Centers, treatment offered in conjunction with justice <br />system programs, or other community -based programs offering <br />evidence -based addiction treatment. This may include capital <br />expenditures for facilities that offer evidence -based treatment for <br />OUD. <br />Page124 <br />